论文部分内容阅读
目的观察联合应用盐酸氨溴索、地塞米松雾化吸入治疗矽肺合并肺部感染的疗效分析。方法将本组84例矽肺合并肺部感染患者按随机方法分成对照组、治疗组。治疗组在常规治疗基础上联合应用雾化吸入盐酸氨溴索、地塞米松治疗,对照组仅用常规治疗加静脉滴入盐酸氨溴索。观察治疗后,两组肺部感染控制时间、症状控制率。结果两组症状均较治疗前减轻,但治疗组症状总有效率明显提高,差异有统计学意义(P<0.05);治疗组较观察组患者症状及肺部感染控制时间明显减少,差异有统计学意义(P<0.05)。结论联合应用盐酸氨溴索、地塞米松雾化吸入治疗矽肺合并肺部感染,安全可靠、疗效明显。
Objective To observe the curative effect of combined use of ambroxol hydrochloride and dexamethasone on inhalation to treat silicosis and pulmonary infection. Methods 84 patients with silicosis and pulmonary infection in this group were randomly divided into control group and treatment group. The treatment group was treated with atomization inhalation of ambroxol hydrochloride and dexamethasone on the basis of routine treatment. The control group was treated with intravenous infusion of ambroxol hydrochloride only by conventional treatment. After observation and treatment, two groups of lung infection control time and symptom control rate. Results The symptoms of both groups were relieved before treatment, but the total effective rate of the treatment group was significantly increased (P <0.05). The symptoms and the control time of lung infection in the treatment group were significantly decreased compared with those in the observation group Significance (P <0.05). Conclusion Combined use of ambroxol hydrochloride and dexamethasone nebulized inhalation for the treatment of silicosis and pulmonary infection is safe and reliable, and the curative effect is obvious.